Curtiss-Wright's Strong Q2 and Nuclear Growth Offset Valuation Concerns
Q2 Earnings Beat and Guidance Raise Curtiss-Wright reported Q2 sales up 5% to $924 million, operating income up 12%, and free cash flow up 37% to $160 million. Management raised full-year guidance, signaling confidence in continued growth. This positive news supports a higher stock price as it reflects strong execution and future earnings potential.
This is the most recent and significant event, directly impacting CW's valuation and investor sentiment.
Nuclear Expansion and DOE Loan Commitment Curtiss-Wright expects an AP1000 reactor order by year-end, backed by a conditional $17.5 billion DOE loan for up to 10 reactors. The company aims to quadruple commercial nuclear revenues to $1.5 billion by mid-next decade. This long-term growth driver adds significant upside potential, boosting investor optimism.
This highlights a major growth avenue that could substantially increase future revenues, a key factor for long-term investors.
Valuation Risk and Stock Pullback Despite strong results, CW's stock fell 8% after earnings and trades at $688.63. Its P/E of 47.7x is above the industry average of 39.9x, suggesting overvaluation. If sentiment cools, the stock could face further downside, as investors may question the high multiple relative to peers.
This counterweight explains why the stock dropped despite good news and highlights a key risk for investors.
Record Defense Spending and Strong Backlog Global military spending hit a record $2.9 trillion in 2025, and CW's new orders rose 16% to a $4.3 billion backlog, with 90% expected to convert to revenue within three years. This robust demand environment supports future revenue growth and earnings stability.
This underscores the strong demand backdrop that underpins CW's growth trajectory, a fundamental driver.